Intervenciones nutricionales emergentes para el síndrome de intestino irritable: dieta reducida en almidón y sacarosa, y dieta Mediterránea
DOI:
https://doi.org/10.52787/agl.v55i2.504Palabras clave:
Síndrome de intestino irritable, terapia dietética, dieta mediterránea, dieta reducida en almidón y sacarosaResumen
El síndrome de intestino irritable es el trastorno gastrointestinal funcional más frecuente y afecta significativamente la calidad de vida. Si bien la intervención nutricional con mayor respaldo científico y más recomendada por las guías internacionales es la dieta baja en FODMAP, un número relevante de pacientes (entre 20% y 50%) no responde adecuadamente. Esto ha impulsado la exploración de otras alternativas de intervención nutricional, como son la dieta reducida en almidón y sacarosa y la dieta mediterránea. El objetivo de este estudio es revisar la evidencia científica disponible acerca de las nuevas estrategias nutricionales para el manejo del síndrome de intestino irritable, con foco en la dieta reducida en almidón y sacarosa y la dieta mediterránea.
Citas
-1. Chey WD, Hashash JG, Manning L, Chang L. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology. 2022 May;162(6):1737-45.e5.
-2. Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021 Jan;160(1):99-114.e3.
-3. Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology [Internet]. 2016 Feb 19; Available from: http://dx.doi.org/10.1053/j.gastro.2016.02.032
-4. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016 May;150(6):1257-61.
-5. Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020 Nov 21;396(10263):1675-88.
-6. Zhang H, Su Q. Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome. Nutrients [Internet]. 2025 Jan 31;17(3). Available from: http://dx.doi.org/10.3390/nu17030544
-7. Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013 May;108(5):634-41.
-8. Ford AC, Staudacher HM, Talley NJ. Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target. Gut. 2024 Jun 6;73(7):1199-211.
-9. Gibson PR. History of the low FODMAP diet. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:5-7.
-10. Farré R, Tack J. Food and symptom generation in functional gastrointestinal disorders: physiological aspects. Am J Gastroenterol. 2013 May;108(5):698-706.
-11. Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021 Jul;70(7):1214-40.
-12. Whelan K, Ford AC, Burton-Murray H, Staudacher HM. Dietary management of irritable bowel syndrome: considerations, challenges, and solutions. Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1147-61.
-13. McKenzie YA, Bowyer RK, Leach H, Gulia P, Horobin J, O’Sullivan NA, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. 2016 Oct;29(5):549-75.
-14. Mitchell H, Porter J, Gibson PR, Barrett J, Garg M. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment Pharmacol Ther. 2019 Jan;49(2):124-39.
-15. Sultan N, Varney JE, Halmos EP, Biesiekierski JR, Yao CK, Muir JG, et al. How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice. J Neurogastroenterol Motil. 2022 Jul 30;28(3):343-56.
-16. Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet. 2018 Apr;31(2):239-55.
-17. Halmos EP, Gibson PR. Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome. J Gastroenterol Hepatol. 2019 Jul;34(7):1134-42.
-18. Halmos E. A FODMAP gentle approach [Internet]. Monash Fodmap; 2020 [cited 2025 Jun 9]. Available from: http://www.monashfodmap.com/blog/gentle-fodmap-diet/
-19. Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, et al. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPS Diet in Treating Symptoms of Irritable Bowel Syndrome. Official journal of the American College of Gastroenterology | ACG. 2018 Sep;113(9):1290.
-20. Haghbin H, Hasan F, Gangwani MK, Zakirkhodjaev N, Lee-Smith W, Beran A, et al. Efficacy of Dietary Interventions for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. J Clin Med [Internet]. 2024 Dec 11;13(24). Available from: http://dx.doi.org/10.3390/jcm13247531
-21. Cuffe MS, Staudacher HM, Aziz I, Adame EC, Krieger-Grubel C, Madrid AM, et al. Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2025 Jun;10(6):520-36.
-22. Arabpour E, Alijanzadeh D, Sadeghi A, Khoshdel S, Hekmatdoost A, Kord-Varkaneh H, et al. Gluten restriction in irritable bowel syndrome, yes or no?: a GRADE-assessed systematic review and meta-analysis. Front Nutr. 2023 Nov 1;10:1273629.
-23. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013 Aug;145(2):320-8.e1-3.
-24. Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, et al. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology. 2018 Feb;154(3):529-39.e2.
-25. Roth B, Nseir M, Jeppsson H, D’Amato M, Sundquist K, Ohlsson B. A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study. Nutrients [Internet]. 2024 Sep 9;16(17). Available from: http://dx.doi.org/10.3390/nu16173039
-26. Henström M, Diekmann L, Bonfiglio F, Hadizadeh F, Kuech EM, von Köckritz-Blickwede M, et al. Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut. 2018 Feb;67(2):263-70.
-27. CSID Cares [Internet]. 2024 [cited 2025 Jun 6]. Choosing Your Foods. Available from: https://www.csidcares.org/treatment/diet/
-28. Nilholm C, Larsson E, Roth B, Gustafsson R, Ohlsson B. Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients. Nutrients [Internet]. 2019 Jun 5;11(6). Available from: http://dx.doi.org/10.3390/nu11061279
-29. Nilholm C, Roth B, Ohlsson B. A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients. Nutrients [Internet]. 2019 Jul 20;11(7). Available from: http://dx.doi.org/10.3390/nu11071662
-30. Nilholm C, Larsson E, Sonestedt E, Roth B, Ohlsson B. Assessment of a 4-Week Starch- and Sucrose-Reduced Diet and Its Effects on Gastrointestinal Symptoms and Inflammatory Parameters among Patients with Irritable Bowel Syndrome. Nutrients [Internet]. 2021 Jan 28;13(2). Available from: http://dx.doi.org/10.3390/nu13020416
-31. Ohlsson B. Theories behind the effect of starch- and sucrose-reduced diets on gastrointestinal symptoms in irritable bowel syndrome (Review). Mol Med Rep [Internet]. 2021 Oct;24(4). Available from: http://dx.doi.org/10.3892/mmr.2021.12372
-32. Gayoso L, Garcia-Etxebarria K, Arzallus T, Montalvo I, Lizasoain J, D’Amato M, et al. The effect of starch- and sucrose-reduced diet accompanied by nutritional and culinary recommendations on the symptoms of irritable bowel syndrome patients with diarrhoea. Therap Adv Gastroenterol. 2023 Apr 28;16:17562848231156682.
-33. Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean Diet; a Literature Review. Nutrients. 2015 Nov 5;7(11):9139-53.
-34. Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Jul;50(2):132-43.
-35. So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, et al. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 2018 Jun 1;107(6):965-83.
-36. Edwards CA, Havlik J, Cong W, Mullen W, Preston T, Morrison DJ, et al. Polyphenols and health: Interactions between fibre, plant polyphenols and the gut microbiota. Nutr Bull. 2017 Dec;42(4):356-60.
-37. Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J, et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut. 2019 Aug;68(8):1417-29.
-38. The effect of a Mediterranean diet on the symptoms of depression in young males (the “AMMEND: A Mediterranean Diet in MEN with Depression” study): a randomized controlled trial. The American Journal of Clinical Nutrition. 2022 Aug 1;116(2):572-80.
-39. Shafiei F, Salari-Moghaddam A, Larijani B, Esmaillzadeh A. Mediterranean diet and depression: reanalysis of a meta-analysis. Nutr Rev. 2023 Mar 16;81(7):889-90.
-40. Marx W, Lane M, Hockey M, Aslam H, Berk M, Walder K, et al. Diet and depression: exploring the biological mechanisms of action. Molecular Psychiatry. 2020 Nov 3;26(1):134-50.
-41. Staudacher HM, Mahoney S, Canale K, Opie RS, Loughman A, So D, et al. Clinical trial: A Mediterranean diet is feasible and improves gastrointestinal and psychological symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2024 Feb;59(4):492-503.
-42. Chen EY, Mahurkar-Joshi S, Liu C, Jaffe N, Labus JS, Dong TS, et al. The Association Between a Mediterranean Diet and Symptoms of Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2024 Jan;22(1):164-72.e6.
-43. Kasti AN, Katsas K, Pavlidis DE, Stylianakis E, Petsis KI, Lambrinou S, et al. Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS-Randomized Controlled Study and Volatomics Analysis. Nutrients [Internet]. 2025 Apr 30;17(9). Available from: http://dx.doi.org/10.3390/nu17091545
-44. Rustom JN. The Efficacy of the Low-FODMAP Diet to Alleviate Symptoms of Irritable Bowel Syndrome in Adults: A Systematic Review. 2021.
-45. Mirmiran P, Bahadoran Z, Gaeini Z. Common Limitations and Challenges of Dietary Clinical Trials for Translation into Clinical Practices. Int J Endocrinol Metab. 2021 Jul;19(3):e108170.
-46. Yao CK, Gibson PR, Shepherd SJ. Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders. Am J Gastroenterol. 2013 May;108(5):748-56.
-47. Gibson PR, Halmos EP, So D, Yao CK, Varney JE, Muir JG. Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey. J Gastroenterol Hepatol. 2022 Apr;37(4):644-52.
-48. Roth B, Ohlsson B. Challenges of recruitment processes to a randomized dietary trial in irritable bowel syndrome. F1000Res. 2024 Jun 24;13:323.
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Sara Noemí Schaab, María Cielo Gutiérrez
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
